Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Takahashi, Masae; | Tezuka, Tadashi | Korant, Bruce | Katunuma, Nobuhiko
Affiliations: Department of Dermatology, Kinki University School of Medicine, 377‐2 Ohno‐Higashi, Osaka‐Sayama, Osaka 589‐8511, Japan | Research and Development, Du Pont Merck, P.O.Box 80336, Wilmington, DE 19880‐0336, USA | Institute for Health Sciences, Tokushima Bunri University, Yamashiro, Tokushima, Tokushima 770‐8514, Japan
Note: [] Corresponding author. Tel.: +81 723 66 0221; Fax: +81 723 68 2120.
Abstract: The inhibitory properties of phosphorylated cystatin \alpha (P‐cystatin \alpha) and a conjugated protein of the P‐cystatin \alpha with filaggrin linker segment peptide (FLSP) against the growth of Staphylococcus bacteria and poliovirus were investigated. Both the P‐cystatin \alpha and the conjugated protein (P‐cystatin \alpha‐FLSP conjugate) as a model for the cornified envelope of skin inhibited the cysteine protease activity of Staphylococcus aureus V8. The protease activity was inhibited by normal cornified envelope of newborn rat skin, which contains P‐cystatin \alpha, and P‐cystatin \alpha in cornified envelope of newborn rat skin also suppressed the growth of S. aureus V8. When P‐cystatin \alpha or P‐cystatin \alpha‐FLSP conjugate was added to cultured HeLa cells infected with poliovirus, 50–70% of the cell‐death due to poliovirus infection was prevented. The poliovirus 3C protease activity in the infected HeLa cells was inhibited by P‐cystatin \alpha or P‐cystatin \alpha‐FLSP conjugate. As a result, the processing of viral capsid peptides was suppressed. These findings suggest that P‐cystatin \alpha and P‐cystatin \alpha‐FLSP conjugate could play the role of the barrier against microorganism infections due to inhibition of their cysteine protease activities.
Keywords: Phosphorylated cystatin [TeX:] \alpha, filaggrin linker segment peptide, epidermal barrier function
Journal: Biofactors, vol. 10, no. 4, pp. 339-345, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl